Bide Pharmatech Soars 8.35%, Hits Intraday High of CNY 52.78

Bide Pharmatech Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.35% on March 24, 2026. The stock reached an intraday high of CNY 52.78, marking a notable moment in its trading activity. This performance stands in contrast to the China Shanghai Composite, which saw a more modest increase of 1.78% on the same day. Despite the positive movement today, Bide Pharmatech's performance over the past week and month has been less favorable, with declines of 7.43% and 11.37%, respectively. Year-to-date, the stock has decreased by 13.92%, reflecting broader market trends. However, the company has reported strong financial metrics, including a record net sales figure of CNY 351.58 million and a notable debtors turnover ratio of 4.88 times. With a market capitalization of CNY 2,235 million, Bide Pharmatech operates within the pharmaceuticals and biotechnology sector. The company maintains a return on equity of 6.97% and a price-to-book ratio of 3.56, indicating a solid valuation in the current market landscape.